Ozempic can reduce insulin doses, research demonstrates
Time in range among people with diabetes lower when insulin doses are missed
Deadline fast approaching for Rowan Hillson Award 2024
The application window for the annual Rowan Hillson Inpatient Safety Award is closing soon, with the deadline set for next month. Healthcare professionals who have been at the forefront of ...
CamDiab secures FDA approval for advanced adaptive hybrid closed loop app CamAPS FX
CamDiab has received authorisation from The Food and Drug Administration (FDA) in the US for its advanced adaptive hybrid closed loop app, CamAPS FX, as an ‘interoperable automated glycaemic ...
Empagliflozin may be effective as diabetic peripheral neuropathy therapy, study reveals
Insulin Safety Week 2024 – Record numbers enjoy free educational webinar
As part of the buildup to Insulin Safety Week 2024, a recent webinar proved a resounding success, attracting healthcare professionals from across the UK and Ireland to increase their ...
Combination of SLT2is and GLP-1RAs offers ‘favourable’ outcomes for treating type 2 diabetes
Charity calls for action to tackle alarming rise in cases of type 2 diabetes among under 40s
Cases of younger people being diagnosed with type 2 diabetes in the UK are rising to ‘alarming levels’, a charity has warned. A new report, published by Diabetes UK for Type 2 Diabetes ...
Nursing group raises thousands to improve diabetes care in Sierra Leone
The Diabetes Specialist Nurse (DSN) Forum UK has raised more than £3,000 to enable healthcare teams in Sierra Leone to buy lifesaving diabetes resources. During a recent fundraising trip to the ...
Diabetes risk higher among women affected by gestational diabetes, study reports
Women living with, or who have been affected by, gestational diabetes are more at risk of developing subsequent diabetes, latest research has suggested. Scientists from McGill University in ...